WANG, XIAODONG,ZHANG, WEIHE,FRYE, STEPHEN,KIREEV, DMITRI
申请号：
CA2945129
公开号：
CA2945129A1
申请日:
2015.04.03
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention includes pyrrolopyrimidine compounds that selectively inhibit Mer tyrosine kinase (MerTK) activity and/or Tyro3 tyrosine kinase activity, and use of these pyrrolopyrimidine compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, anti-infective agents, and as adjunctive agents in combination with chemotherapeutic, radiation or other standard of care for neoplasms.
